Total Payments
$2,616
2024 Payments
$870.59
Companies
14
Transactions
31
Medicare Patients
729
Medicare Billing
$291,121
Payment Breakdown by Category
Food & Beverage$2,315 (88.5%)
Education$301.23 (11.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,315 | 22 | 88.5% |
| Education | $301.23 | 9 | 11.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $484.45 | 4 | $0 (2024) |
| Amgen Inc. | $455.92 | 5 | $0 (2024) |
| Baxter Healthcare | $243.44 | 2 | $0 (2018) |
| Travere Therapeutics, Inc. | $225.61 | 2 | $0 (2024) |
| Mallinckrodt LLC | $224.34 | 3 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $221.54 | 2 | $0 (2018) |
| Mallinckrodt Hospital Products Inc. | $155.85 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $121.73 | 1 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $111.25 | 1 | $0 (2024) |
| GENZYME CORPORATION | $93.49 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $870.59 | 8 | Bayer Healthcare Pharmaceuticals Inc. ($246.78) |
| 2023 | $687.74 | 9 | Bayer Healthcare Pharmaceuticals Inc. ($237.67) |
| 2022 | $20.08 | 1 | Amgen Inc. ($20.08) |
| 2019 | $89.98 | 1 | Horizon Therapeutics plc ($89.98) |
| 2018 | $316.35 | 4 | Novartis Pharmaceuticals Corporation ($115.51) |
| 2017 | $631.02 | 8 | Mallinckrodt LLC ($224.34) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $124.97 | General |
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Cardio-renal | ||||||
| 07/24/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: NEPHROLOGY | ||||||
| 05/17/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $111.25 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: Cardio-renal | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: Inflammation | ||||||
| 01/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: Inflammation | ||||||
| 12/06/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Education | In-kind items and services | $10.30 | General |
| Category: CRITICAL CARE | ||||||
| 10/11/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: CRITICAL CARE | ||||||
| 10/04/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $10.30 | General |
| Category: IMMUNOLOGY | ||||||
| 08/31/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $100.64 | General |
| 06/28/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: Inflammation | ||||||
| 06/20/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $103.79 | General |
| Category: Cardio-renal | ||||||
| 05/16/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $10.30 | General |
| Category: IMMUNOLOGY | ||||||
| 03/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $133.88 | General |
| Category: Cardio-renal | ||||||
| 01/11/2023 | Amgen Inc. | TAVNEOS (Drug) | Education | In-kind items and services | $72.45 | General |
| Category: Inflammation | ||||||
| 06/22/2022 | Amgen Inc. | Tavneos (Drug) | Education | In-kind items and services | $20.08 | General |
| Category: Not Applicable | ||||||
| 12/11/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $89.98 | General |
| Category: KRYSTEXXA | ||||||
| 10/18/2018 | Astute Medical, Inc. | Nephrocheck (Device) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: Nephrology | ||||||
| 09/25/2018 | Astute Medical, Inc. | Nephrocheck (Device) | Food and Beverage | In-kind items and services | $85.26 | General |
| Category: Nephrology | ||||||
| 06/28/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $115.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/26/2018 | Baxter Healthcare | Renal - Chronic (Device) | Food and Beverage | In-kind items and services | $111.58 | General |
| Category: Renal | ||||||
| 11/30/2017 | BAXTER HEALTHCARE | Renal - Non Product Related (Biological) | Food and Beverage | In-kind items and services | $131.86 | General |
| Category: Renal | ||||||
| 10/05/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 93 | 307 | $82,236 | $36,065 |
| 2022 | 6 | 139 | 383 | $101,764 | $43,933 |
| 2021 | 9 | 250 | 1,529 | $243,075 | $109,872 |
| 2020 | 8 | 247 | 1,502 | $257,003 | $101,251 |
Total Patients
729
Total Services
3,721
Medicare Billing
$291,121
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 12 | 60 | $30,000 | $13,572 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 151 | $29,596 | $13,283 | 44.9% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 13 | 35 | $14,100 | $5,514 | 39.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 61 | $8,540 | $3,696 | 43.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 15 | 60 | $30,000 | $14,026 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 140 | $27,440 | $12,189 | 44.4% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 14 | 48 | $19,200 | $7,336 | 38.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 101 | $14,140 | $5,708 | 40.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 18 | $6,984 | $2,675 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,000 | $1,999 | 50.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 20 | 152 | $91,200 | $43,437 | 47.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 46 | 251 | $35,140 | $14,253 | 40.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 154 | $30,184 | $13,716 | 45.4% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 22 | 46 | $23,000 | $11,012 | 47.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 43 | 57 | $22,116 | $8,850 | 40.0% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 11 | 37 | $14,800 | $6,045 | 40.8% |
| 90970 | Dialysis services, per day (less than full month service), patient 20 years of age or older | Office | 2021 | 22 | 759 | $11,385 | $5,908 | 51.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 60 | $12,000 | $4,893 | 40.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,250 | $1,758 | 54.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 24 | 143 | $85,800 | $32,778 | 38.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 46 | 274 | $38,360 | $16,053 | 41.8% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 24 | 69 | $34,500 | $13,004 | 37.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 167 | $32,732 | $12,696 | 38.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 37 | 57 | $22,116 | $9,153 | 41.4% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 11 | 48 | $19,200 | $7,163 | 37.3% |
About Dr. Fernando Rodriguez, MD
Dr. Fernando Rodriguez, MD is a Nephrology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962425165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fernando Rodriguez, MD has received a total of $2,616 in payments from pharmaceutical and medical device companies, with $870.59 received in 2024. These payments were reported across 31 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,315).
As a Medicare-enrolled provider, Rodriguez has provided services to 729 Medicare beneficiaries, totaling 3,721 services with total Medicare billing of $291,121. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Tampa, FL
- Active Since 07/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1962425165
Products in Payments
- Kerendia (Drug) $484.45
- TAVNEOS (Drug) $435.84
- ACTHAR (Biological) $244.94
- ENTRESTO (Drug) $221.54
- TERLIVAZ (Drug) $135.25
- Renal - Non Product Related (Biological) $131.86
- FARXIGA (Drug) $121.73
- Renal - Chronic (Device) $111.58
- LUPKYNIS (Drug) $111.25
- FABRAZYME (Drug) $93.49
- KRYSTEXXA (Biological) $89.98
- Nephrocheck (Device) $89.26
- GATTEX (Drug) $75.30
- JYNARQUE (Drug) $23.60
- Tavneos (Drug) $20.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Tampa
Sean Verma, Md, MD
Nephrology — Payments: $15,586
Nephrology $15,586
Mr. Gustavo Serrano, Md, MD
Nephrology — Payments: $8,652
Nephrology $8,652
Vijay Patel, Md, MD
Nephrology — Payments: $7,721
Nephrology $7,721
Dr. Venkata Reddivari, M.d, M.D
Nephrology — Payments: $6,564
Nephrology $6,564
Dr. Rajendra Baliga, M.d, M.D
Nephrology — Payments: $4,777
Nephrology $4,777
Chhavi Gupta, Md, MD
Nephrology — Payments: $4,625
Nephrology $4,625